Abstract

Despite inducing very low IFN-γ response and highly attenuated in vivo, infection of mice with phosphoglycan (PG) deficient Leishmania major (lpg2-) induces protection against virulent L. major challenge. Here, we show that mice infected with lpg2- L. major generate Leishmania-specific memory T cells. However, in vitro and in vivo proliferation, IL-10 and IFN-γ production by lpg2- induced memory cells were impaired in comparison to those induced by wild type (WT) parasites. Interestingly, TNF recall response was comparable to WT infected mice. Despite the impaired proliferation and IFN-γ response, lpg2- infected mice were protected against virulent L. major challenge and their T cells mediated efficient infection-induced immunity. In vivo depletion and neutralization studies with mAbs demonstrated that lpg2- L. major-induced resistance was strongly dependent on IFN-γ, but independent of TNF and CD8+ T cells. Collectively, these data show that the effectiveness of secondary anti-Leishmania immunity depends on the quality (and not the magnitude) of IFN-γ response. These observations provide further support for consideration of lpg2- L. major as a live-attenuated candidate for leishmanization in humans since it protects strongly against virulent challenge, without inducing pathology in infected animals.

Highlights

  • Leishmaniasis is a serious global health problem that affects millions of people worldwide, especially in developing tropical and subtropical countries

  • We investigated the correlates and possible mechanism of lpg2- mediated protection in murine cutaneous leishmaniasis

  • We demonstrated that lpg2-infected mice contain Leishmania-reactive cells that rapidly proliferate and produce effector cytokines (IFN-c and tumor necrosis factor (TNF)) in response to Leishmania antigen stimulation in vivo and in vitro

Read more

Summary

Introduction

Leishmaniasis is a serious global health problem that affects millions of people worldwide, especially in developing tropical and subtropical countries. Following recovery from primary natural or experimental infection with L. major, a state of immunity develops that is able to rapidly protect healed animals (both humans and mice) against secondary challenge [6]. Such infection-acquired immunity is very durable and is mediated by IFN-c-producing effector and central memory-like T cells [7]. We show that despite significant differences in quantity, the secondary anti-Leishmania immunity induced by WT and lpg parasites are qualitatively similar These findings further support the consideration of lpg parasites as live attenuated vaccine candidate against cutaneous leishmaniasis

Materials and Methods
Results
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.